Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
Integrating molecular profiling into current clinical stratification could improve outcomes in rhabdomyosarcoma, according to researchers.
Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures.
A new review points to low rates of genetic testing in patients with ovarian cancer.
A 10% reduction in calorie intake during the first month of treatment shows promise for augmenting chemotherapy treatment in children and adolescents with ALL.
A comprehensive review provides clinical pearls and approaches to consider regarding chemoradiotherapy for patients with stage III non-small cell lung cancer.
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
Ajai Chari, MD, of Mount Sinai Hospital in New York City, provides his perspective on the current state of care in multiple myeloma.
Photobiomodulation shows impressive results in pretrial use for treatment and prevention of treatment-associated mucositis in pediatric patients.
Investigators assessed disparities in patient access to therapies approved for the treatment of gastrointestinal malignancies in the United States, the United Kingdom, Europe, and Ireland, as well as benefit relative to cost.